Profils

Nav datu attēlošanai.

Systems by mikeswierc

Vārds
Pieaugums
Kritums (Drawdown)
Sneigums
PROP FIRMS US30 TEST RUN PASSING CHALLENGE
Demo
1:500
MetaTrader 4
+2.82%
42.09%
PROP FIRMS US30 TEST RUN PASSING CHALLENGE performance

Jaunākās Publikācijas

mikeswierc's Reviews

Nav datu attēlošanai.

Charts Activity

Nav datu attēlošanai.
Tools
Ekonomisko notikumu kalendārs
Tirgus darba laiks
Procentu likmes
Svētku kalendārs
Valūtu Tirgus
Forex Volatility
Forex Correlation
Streaming Forex News
Forex analīze
COT dati
Likviditāte
Forex Calculators
Forex Heat Map
Ekonomikas rādītājs Valūtas kalkulator
Kopiena
Kopiena
Sistēmas
Most Popular Systems
Stratēģijas
Konkursi
Forex Charts
Komunikācijas apskats
Sentiment Indicator
Apskats
Brokeri
Proprietārās tirdzniecības firmas
VPS Services
Signālu provaiders
EA Programming Services
Partnerprogrammas
PAMM Broker Services
Rebate Program Services
Trading Platforms
Padomnieki (Expert Advisors)
Crypto Exchanges
Tirdzniecības kursi
Akciju Portfeļa Izsekotāji
Brokeri
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions
Preses Relīze
Platforma
Logrīki
Funkcijas
API
RSS
Stock Portfolio
Affiliate Software
Izvērsta diagramma
Atbalsts
BUJ
Palīdzība
Kontaktēties ar mums
Ziņotas par kļūdu!
Par
Blogs
© 2026 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.